Update: 11.04.2023
Last week: 13 week 2023 (27.03.2023 - 02.04.2023)
Last full month: March 2023
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 87 320 | -7.3% | 2.6% | 0 | 22 288 798 | -7.5% | 3.0% | 0 | -8.2% |
| MoM | 435 862 | 5.7% | 2.7% | 0 | 112 473 444 | 0.4% | 3.2% | -0.2 | 5.5% |
| YTD | 1 372 646 | -67.8% | 2.7% | -3.3 | 365 917 672 | -56.1% | 3.4% | -2.5 | -28.9% |
| MAT | 6 956 980 | -54.3% | 3.7% | -2.9 | 1 552 394 222 | -43.3% | 3.9% | -2.2 | -18.9% |
| DEXALGIN | |||||||||
| WoW | 17 583 | -0.1% | 0.4% | 0 | 9 233 642 | 0.3% | 1.1% | 0 | -0.8% |
| MoM | 74 776 | 24.2% | 0.3% | 0 | 39 532 681 | 19.7% | 1.1% | 0 | 18.7% |
| YTD | 223 118 | -64.9% | 0.4% | -0.4 | 119 290 407 | -53.7% | 1.2% | -1 | -22.5% |
| MAT | 1 173 870 | -42.6% | 0.5% | -0.2 | 548 464 234 | -31.2% | 1.4% | -0.6 | -13.3% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 60 999 | -1.6% | 40.1% | -0.5 | 37 441 551 | -2.0% | 48.6% | -1.2 | -0.4% |
| MoM | 260 079 | 28.7% | 40.6% | 2.1 | 162 126 903 | 26.5% | 49.8% | 1.6 | 22.2% |
| YTD | 700 176 | -57.0% | 39.6% | -20.3 | 444 241 625 | -45.1% | 49.5% | -16.3 | -34.9% |
| MAT | 3 357 430 | -39.5% | 47.3% | -15.9 | 1 844 022 580 | -30.1% | 54.1% | -14.5 | -19.0% |
| ESPUMISAN BABY | |||||||||
| WoW | 22 404 | -0.6% | 30.4% | 0.8 | 17 030 287 | -0.8% | 46.5% | 0.8 | -3.3% |
| MoM | 96 604 | 19.7% | 29.4% | 0.1 | 74 163 891 | 17.5% | 45.7% | -0.8 | 19.3% |
| YTD | 270 476 | -42.7% | 29.5% | -10.4 | 209 920 534 | -26.4% | 46.3% | -7.7 | -22.5% |
| MAT | 1 224 815 | -27.1% | 34.1% | -6.5 | 830 230 967 | -16.6% | 48.2% | -6.9 | -13.1% |
| FASTUM | |||||||||
| WoW | 15 254 | -3.0% | 0.8% | 0 | 9 230 798 | -3.2% | 2.2% | 0 | -1.3% |
| MoM | 66 470 | 24.7% | 0.8% | 0 | 40 100 012 | 24.1% | 2.2% | 0 | 26.8% |
| YTD | 190 413 | -49.1% | 0.9% | -0.6 | 115 867 894 | -37.5% | 2.3% | -0.6 | -15.5% |
| MAT | 856 565 | -37.7% | 0.9% | -0.5 | 476 762 637 | -26.7% | 2.3% | -0.7 | -6.5% |
| IODOMARIN | |||||||||
| WoW | 79 197 | -8.8% | 23.9% | -1.2 | 14 587 562 | -8.4% | 10.0% | -0.5 | -4.2% |
| MoM | 349 294 | 32.6% | 23.7% | 1.4 | 64 750 326 | 31.0% | 9.9% | 0.8 | 24.8% |
| YTD | 885 447 | -6.6% | 22.4% | 2.8 | 164 612 067 | -10.4% | 9.0% | 0.5 | -18.3% |
| MAT | 3 230 477 | -4.8% | 21.3% | 0.4 | 620 987 887 | -3.0% | 9.2% | -0.1 | -6.7% |
| LIOTON | |||||||||
| WoW | 20 562 | 11.2% | 1.9% | 0.2 | 25 334 861 | 7.8% | 4.5% | 0.4 | -1.5% |
| MoM | 77 411 | 18.7% | 1.6% | -0.2 | 97 815 660 | 19.3% | 4.1% | -0.6 | 32.2% |
| YTD | 206 533 | -53.0% | 1.7% | -1 | 258 858 755 | -39.7% | 4.3% | -1 | -25.1% |
| MAT | 1 018 390 | -42.1% | 1.9% | -0.9 | 1 136 975 794 | -26.0% | 4.3% | -1.3 | -16.1% |
| MEZYM | |||||||||
| WoW | 217 081 | -1.1% | 18.3% | 0.4 | 34 415 542 | -1.5% | 12.2% | 0 | -3.3% |
| MoM | 975 082 | 21.9% | 18.5% | -0.8 | 154 752 854 | 22.6% | 12.7% | -0.3 | 27.4% |
| YTD | 2 800 743 | -59.4% | 19.1% | -11.9 | 440 633 308 | -58.0% | 13.0% | -9.2 | -34.2% |
| MAT | 13 244 945 | -41.5% | 21.8% | -8.3 | 2 036 325 226 | -37.5% | 15.3% | -6.8 | -19.2% |
| MIG 400 | |||||||||
| WoW | 128 002 | 1.4% | 2.6% | 0.1 | 15 592 015 | 2.4% | 1.9% | 0 | -0.8% |
| MoM | 539 752 | 36.9% | 2.5% | 0.3 | 63 784 644 | 36.6% | 1.8% | 0.2 | 18.7% |
| YTD | 1 443 389 | -46.7% | 2.3% | -1.1 | 175 451 638 | -44.1% | 1.8% | -0.9 | -22.5% |
| MAT | 7 130 004 | -32.8% | 2.9% | -0.8 | 855 676 786 | -28.9% | 2.2% | -0.8 | -13.3% |
| PROSTAMOL | |||||||||
| WoW | 20 405 | -8.6% | 11.8% | -0.7 | 30 354 654 | -7.9% | 13.0% | -0.6 | -3.5% |
| MoM | 97 107 | 20.6% | 12.7% | -0.3 | 145 099 537 | 18.6% | 14.0% | -0.5 | 23.0% |
| YTD | 272 844 | -55.5% | 13.1% | -9.4 | 410 340 295 | -52.1% | 14.6% | -9.3 | -23.7% |
| MAT | 1 205 953 | -44.5% | 15.4% | -8.7 | 1 718 733 019 | -39.4% | 16.4% | -9.3 | -13.0% |
| RESPERO MYRTOL | |||||||||
| WoW | 22 674 | -4.5% | 6.9% | 0.1 | 12 223 383 | -5.9% | 7.4% | -0.1 | -5.6% |
| MoM | 102 002 | 8.3% | 6.8% | -0.2 | 56 908 801 | 3.9% | 7.7% | -0.7 | 11.7% |
| YTD | 301 963 | -40.6% | 7.0% | -2.9 | 171 583 452 | -26.3% | 8.1% | -1.5 | -16.4% |
| MAT | 1 095 183 | -6.1% | 7.4% | 0 | 562 303 388 | 5.2% | 8.0% | 0.5 | -6.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 1 372 646 | -67.8% | 2.7% | -3.3 | 365 917 672 | -56.1% | 3.4% | -2.5 | -28.9% |
| DEXALGIN | 223 118 | -64.9% | 0.4% | -0.4 | 119 290 407 | -53.7% | 1.2% | -1 | -22.5% |
| ESPUMISAN (ADULTS) | 700 176 | -57.0% | 39.6% | -20.3 | 444 241 625 | -45.1% | 49.5% | -16.3 | -34.9% |
| ESPUMISAN BABY | 270 476 | -42.7% | 29.5% | -10.4 | 209 920 534 | -26.4% | 46.3% | -7.7 | -22.5% |
| FASTUM | 190 413 | -49.1% | 0.9% | -0.6 | 115 867 894 | -37.5% | 2.3% | -0.6 | -15.5% |
| IODOMARIN | 885 447 | -6.6% | 22.4% | 2.8 | 164 612 067 | -10.4% | 9.0% | 0.5 | -18.3% |
| LIOTON | 206 533 | -53.0% | 1.7% | -1 | 258 858 755 | -39.7% | 4.3% | -1 | -25.1% |
| MEZYM | 2 800 743 | -59.4% | 19.1% | -11.9 | 440 633 308 | -58.0% | 13.0% | -9.2 | -34.2% |
| MIG 400 | 1 443 389 | -46.7% | 2.3% | -1.1 | 175 451 638 | -44.1% | 1.8% | -0.9 | -22.5% |
| PROSTAMOL | 272 844 | -55.5% | 13.1% | -9.4 | 410 340 295 | -52.1% | 14.6% | -9.3 | -23.7% |
| RESPERO MYRTOL | 301 963 | -40.6% | 7.0% | -2.9 | 171 583 452 | -26.3% | 8.1% | -1.5 | -16.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 6 956 980 | -54.3% | 3.7% | -2.9 | 1 552 394 222 | -43.3% | 3.9% | -2.2 | -18.9% |
| DEXALGIN | 1 173 870 | -42.6% | 0.5% | -0.2 | 548 464 234 | -31.2% | 1.4% | -0.6 | -13.3% |
| ESPUMISAN (ADULTS) | 3 357 430 | -39.5% | 47.3% | -15.9 | 1 844 022 580 | -30.1% | 54.1% | -14.5 | -19.0% |
| ESPUMISAN BABY | 1 224 815 | -27.1% | 34.1% | -6.5 | 830 230 967 | -16.6% | 48.2% | -6.9 | -13.1% |
| FASTUM | 856 565 | -37.7% | 0.9% | -0.5 | 476 762 637 | -26.7% | 2.3% | -0.7 | -6.5% |
| IODOMARIN | 3 230 477 | -4.8% | 21.3% | 0.4 | 620 987 887 | -3.0% | 9.2% | -0.1 | -6.7% |
| LIOTON | 1 018 390 | -42.1% | 1.9% | -0.9 | 1 136 975 794 | -26.0% | 4.3% | -1.3 | -16.1% |
| MEZYM | 13 244 945 | -41.5% | 21.8% | -8.3 | 2 036 325 226 | -37.5% | 15.3% | -6.8 | -19.2% |
| MIG 400 | 7 130 004 | -32.8% | 2.9% | -0.8 | 855 676 786 | -28.9% | 2.2% | -0.8 | -13.3% |
| PROSTAMOL | 1 205 953 | -44.5% | 15.4% | -8.7 | 1 718 733 019 | -39.4% | 16.4% | -9.3 | -13.0% |
| RESPERO MYRTOL | 1 095 183 | -6.1% | 7.4% | 0 | 562 303 388 | 5.2% | 8.0% | 0.5 | -6.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 87 320 | -7.3% | 2.6% | 0 | 22 288 798 | -7.5% | 3.0% | 0 | -8.2% |
| DEXALGIN | 17 583 | -0.1% | 0.4% | 0 | 9 233 642 | 0.3% | 1.1% | 0 | -0.8% |
| ESPUMISAN (ADULTS) | 60 999 | -1.6% | 40.1% | -0.5 | 37 441 551 | -2.0% | 48.6% | -1.2 | -0.4% |
| ESPUMISAN BABY | 22 404 | -0.6% | 30.4% | 0.8 | 17 030 287 | -0.8% | 46.5% | 0.8 | -3.3% |
| FASTUM | 15 254 | -3.0% | 0.8% | 0 | 9 230 798 | -3.2% | 2.2% | 0 | -1.3% |
| IODOMARIN | 79 197 | -8.8% | 23.9% | -1.2 | 14 587 562 | -8.4% | 10.0% | -0.5 | -4.2% |
| LIOTON | 20 562 | 11.2% | 1.9% | 0.2 | 25 334 861 | 7.8% | 4.5% | 0.4 | -1.5% |
| MEZYM | 217 081 | -1.1% | 18.3% | 0.4 | 34 415 542 | -1.5% | 12.2% | 0 | -3.3% |
| MIG 400 | 128 002 | 1.4% | 2.6% | 0.1 | 15 592 015 | 2.4% | 1.9% | 0 | -0.8% |
| PROSTAMOL | 20 405 | -8.6% | 11.8% | -0.7 | 30 354 654 | -7.9% | 13.0% | -0.6 | -3.5% |
| RESPERO MYRTOL | 22 674 | -4.5% | 6.9% | 0.1 | 12 223 383 | -5.9% | 7.4% | -0.1 | -5.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 435 862 | 5.7% | 2.7% | 0 | 112 473 444 | 0.4% | 3.2% | -0.2 | 5.5% |
| DEXALGIN | 74 776 | 24.2% | 0.3% | 0 | 39 532 681 | 19.7% | 1.1% | 0 | 18.7% |
| ESPUMISAN (ADULTS) | 260 079 | 28.7% | 40.6% | 2.1 | 162 126 903 | 26.5% | 49.8% | 1.6 | 22.2% |
| ESPUMISAN BABY | 96 604 | 19.7% | 29.4% | 0.1 | 74 163 891 | 17.5% | 45.7% | -0.8 | 19.3% |
| FASTUM | 66 470 | 24.7% | 0.8% | 0 | 40 100 012 | 24.1% | 2.2% | 0 | 26.8% |
| IODOMARIN | 349 294 | 32.6% | 23.7% | 1.4 | 64 750 326 | 31.0% | 9.9% | 0.8 | 24.8% |
| LIOTON | 77 411 | 18.7% | 1.6% | -0.2 | 97 815 660 | 19.3% | 4.1% | -0.6 | 32.2% |
| MEZYM | 975 082 | 21.9% | 18.5% | -0.8 | 154 752 854 | 22.6% | 12.7% | -0.3 | 27.4% |
| MIG 400 | 539 752 | 36.9% | 2.5% | 0.3 | 63 784 644 | 36.6% | 1.8% | 0.2 | 18.7% |
| PROSTAMOL | 97 107 | 20.6% | 12.7% | -0.3 | 145 099 537 | 18.6% | 14.0% | -0.5 | 23.0% |
| RESPERO MYRTOL | 102 002 | 8.3% | 6.8% | -0.2 | 56 908 801 | 3.9% | 7.7% | -0.7 | 11.7% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"## [1] "ESPUMISAN (ADULTS)"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"## [1] "ESPUMISAN BABY"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"## [1] "FASTUM"## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"## [1] "LIOTON"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"## [1] "MEZYM"## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS 20000 IU #20"## [1] "MEZYM FORTE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #80"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS 10000 ED #20"## [1] "DEXALGIN"## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"## [1] "MIG 400"## [1] "MIG 400 COATED TABLETS 400 MG #10"## [1] "MIG 400 COATED TABLETS 400 MG #20"## [1] "PROSTAMOL"## [1] "PROSTAMOL UNO CAPS 320 MG #30"## [1] "PROSTAMOL UNO CAPS 320 MG #60"## [1] "PROSTAMOL UNO CAPS 320 MG #90"## [1] "IODOMARIN"## [1] "IODOMARIN 100 TABS 100 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #50"## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"## [1] "RESPERO MYRTOL"## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs